Reference
Henry A, Charpiat B, Vial T, et al. Pheochromocytoma unmasked by amisulpride and tiapride. Ann Pharmacother 2005 May; 39(5): 970–2
Baciewicz AM, Chandra R. Cefprozil-induced rash in infectious mononucleosis. Ann Pharmacother 2005 May; 39(5): 974–5
Fomin VV, Taronishvili OI, Shvetsov MY, et al. Progressive azotemia provoked by ACE inhibitor in renal ischemia. Ter Ark 2004; 76(9): 66–7
Azar S, Ramjiani A, Van Gerpen JA. Ciprofloxacin-induced chorea. Mov Disord 2005 Apr; 20(4): 513–4
Numata S, Kato O, Misawa H, et al. Left atrial thrombosis associated with antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry 2005 Jan; 29(1): 153–5
Ural AU, Avcu F, Yilmaz MI, et al. Development of squamous cell carcinoma of the tongue during induction chemotherapy for acute myeloid leukemia. Tumori 2005 Jan–Feb; 91(1): 81–3
Poggioli R, Froud T, Baidal DA, et al. Hypereosinophilia in an islet transplant recipient. Transplantation 2005 Apr; 79(7): 853–4
Borrás-Blasco J, Conesa-Garcia V, Navarro-Ruiz A, et al. Pure red cell aplasia associated with dapsone therapy. Ann Pharmacother 2005 Jun; 39(6): 1137–8
Mennecier D, Ceppa F, Gidenne S, et al. Hyponatremia with consciousness disturbance associated with esomeprazole. Ann Pharmacother 2005 Apr; 39(4): 774–5
Varkey Maramattom B, Manno EM, Wijdicks EFM, et al. Gadolinium encephalopathy in a patient with renal failure. Neurology 2005 Apr 12; 64(7): 1276–8
Lin TS, Penza SL, Avalos BR, et al. Diffuse alveolar hemorrhage following gemtuzumab ozogamicin. Bone Marrow Transplant 2005 Apr; 35(8): 823–4
Land MH, Rouster-Stevens K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005 Jan; 115(1): 178–81
Bergeron L, Boulé M, Perreault S. Serotonin toxicity associated with concomitant use of linezolid. Ann Pharmacother 2005 May; 39(5): 956–61
Assche G, Van Ranst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn’s disease. N Engl J Med 2005 [Epub ahead of print]. Available from URL: http://www.content.nejm.org [Accessed 2005 Jun 20]
Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005 [Epub ahead of print]. Available from URL: http://www.content.nejm.org [Accessed 2005 Jun 20]
Langer-Gould A, Atlas SW, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005 [Epub ahead of print]. Available from URL: http://www.content.nejm.org [Accessed 2005 Jun 20]
Sahin MT, Ozturkcan S, Inanir I, et al. Norfloxacin-induced toxic epidermal necrolysis. Ann Pharmacother 2005 Apr; 39(4): 768–70
Lanternier F, Bon C, Memain N, et al. Severe streptococcal cellulitis after subcutaneous pegylated interferon alfa-2B in a diabetic patient. Gastroenterol Clin Biol 2004 Dec; 28(12): 1294–5
Baggott J, Singh AN. Sildenafil-induced relapse in bipolar disorder: is nitric oxide the mechanism? Int J Neuropsychopharmacol 2004 Dec; 7(4): 525
Bertolm-Guillén JM, Climent-Diaz B, Navarré-Gimeno A. Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine. Eur Psychiatry 2004 Nov; 19(7): 456–7
Reed M, Wall GC, Shah NP, et al. Verapamil toxicity resulting from a probable interaction with telithromycin. Ann Pharmacother 2005 Feb; 39(1): 357–60
Rights and permissions
About this article
Cite this article
First reports of serious adverse drug reactions in recent weeks. Drugs Ther. Perspect 21, 18 (2005). https://doi.org/10.2165/00042310-200521080-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200521080-00006